Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in the Women’s Health Initiative Observational Study

BACKGROUND: In the Women’s Health Initiative (WHI) randomized trial, estrogen plus progestin increased both breast cancer incidence and mortality. In contrast, most observational studies associate estrogen plus progestin with favorable prognosis breast cancers. To address differences, a cohort of WH...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chlebowski, Rowan T., Manson, JoAnn E., Anderson, Garnet L., Cauley, Jane A., Aragaki, Aaron K., Stefanick, Marcia L., Lane, Dorothy S., Johnson, Karen C., Wactawski-Wende, Jean, Chen, Chu, Qi, Lihong, Yasmeen, Shagufta, Newcomb, Polly A., Prentice, Ross L.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3691942/
https://ncbi.nlm.nih.gov/pubmed/23543779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djt043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados